Global Enteral Feeding Devices Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Enteral Feeding Pumps, Enteral Feeding Tubes, Enteral Syringes, Others), By Age Group (Adult, Pediatric), By Application (Gastroenterology, Oncology, Neurology, Hypermetabolism, Diabetes, Others), By End-User (Hospitals, Home Care, Ambulatory Care Settings), And By Geography - Forecasts From 2022 To 2027

  • Published : Dec 2022
  • Report Code : KSI061611549
  • Pages : 114

The global enteral feeding devices market is evaluated at US$1,733.074 million for 2020 and is projected to grow at a CAGR of 4.26% to reach the market size of US$2,320.075 million by 2027.

Factors that are expected to drive this notable growth are an increasing number of premature births, rapid improvements in medical facilities in developing countries, and the rising prevalence of chronic diseases like diabetes mellitus, hepatitis B and C, cancer, rheumatoid arthritis, gastrointestinal disease, and CVDs. For instance, gastrointestinal and liver diseases are major causes of death and disability in the Middle East and North African countries. The number of patients suffering from GLDs is highest in Afghanistan, Pakistan, and Egypt. Diarrheal diseases have been replaced by gastrointestinal cancers and cirrhosis in most countries in the region. However, in several countries including Afghanistan, Pakistan, Turkmenistan, Egypt, and Yemen, communicable GILDs are still among the top causes of mortality and morbidity in addition to non-communicable GILDs and cancers. The rising prevalence of GILD cases has significantly increased the demand for healthcare services and equipment, including enteral feeding devices. Moreover, the rising adoption of enteral feeding devices in the home and ambulatory care settings is further projected to drive this notable growth during the forecast period. However, factors such as complications associated with enteral feeding devices, insufficient reimbursement for enteral nutrition, and lack of consumer awareness for procedures using enteral feeding devices are expected to hinder market growth.

Growing geriatric population and rise in prevalence of chronic diseases.

A rising geriatric population that gets bedridden due to various neurological and musculoskeletal disorders is further expected to boost the market growth. In developed countries like Australia, the older population continues to grow and is projected to more than double by 2057. The prevalence of the disease is rising from year to year which will create a huge demand for enteral feeding devices.

Further, the rising prevalence of autoimmune diseases such as cardiovascular disease, diabetes, and cancer is expected to create a huge demand for prefilled syringes in the market. According to the world health organization it was estimated that around 17.9 million people died due to the increasing cases of cardiovascular disease which represents around 32% of all global deaths. The number of people with diabetes was estimated to be around 108 million in 1980 which has increased to 422 million in 2014.

Additionally, growing cases of diarrheal disease are further anticipated to drive the overall market growth. According to the world health organization, diarrhoeal disease kills around 525,000 children under five every year. It is a leading cause of child mortality in the world which results from malnutrition and from contaminated food and water sources. Worldwide, 780 million individuals lack access to drinking water, and 2.5 billion lack improved sanitation.

Key developments

  • Rising investments by key players in the development and advancement of these devices will significantly contribute to overall market growth. For instance, in Sept 2021, Enteral Access Technologies (EAT), a medical device company in Liverpool received the CE Mark for its DoubleCHEK device. During the same year, Vonco Products’ EnteraLoc Flow direct-connect enteral nutritional delivery system received 510 (K) clearance from the US Food and Drug Administration (USFDA). The system has a pouch and tube for food delivery and can deliver nutrition in either a hospital or home care setting.
  • In February 2021, Amsino Medical Group received clearance for its Puggle enteral feeding pump and set from U.S. Food and Drug Administration’s 510(k). The product is designed to provide nutrition to the pediatric as well as adults with the feeding tube patient population.
  • In July 2021, the US Food and Drug Administration (FDA) approved Medtronic Diabetes' extended-wear infusion set, intended to last more than twice as long as current infusion sets and link conventional tubed pumps to the body for the administration of insulin.

North America is anticipated to dominate the overall market

Geographically, the global enteral feeding devices market has been classified into North America, Europe, the Middle East and Africa, South America, and the Asia Pacific. Countries like India and China are anticipated to have considerable market growth during the forecast period. The growth is attributed due to the rise in the prevalence of diabetes, India has 77 million people that are suffering from diabetes in the 20-79 years age group followed by China which has 116 million adults with diabetes. The growth is mainly contributed by the countries that lie in the western pacific and southeast Asia (Source: IDF). North America is anticipated to dominate the overall market growth due to the rising adoption of this device followed by advanced treatment approaches in healthcare. Moreover, the high prevalence of the chronic disease across the region will further increase the demand for enteral feeding devices. In 2020, an estimated 1.86 million cases of cancer were diagnosed in the United States and more than 55,000 people died from the disease (Source: National Cancer Institute). The enteral feeding devices market in North America is projected to be driven by favorable funding from the government and continuous research, prevention, and treatment in the United States.

COVID-19 Impact on Enteral Feeding Devices Market

The COVID-19 pandemic positively impacted the enteral feeding devices market. However, the market grew lower than its potential. The virus severely impacted the impacted person’s immune system, making them weak, and fragile, and hence causing death. Numerous patients lost their sense of taste and smell and found swelling food difficult. These patients then had to be fed using external devices to fuel body strength and fight the virus. An exponential spread of the virus, rising cases, and its severe impact on people, especially the aged and those with chronic disease, created promising demand. But supply chain constraints limited the market, hindering it to reach its potential. Furthermore, slackening demand by the household and clinic setup, owing to the temporary shutdown of clinics and fear among patients, also dwindles the market growth.

Global Enteral Feeding Devices Market Scope:

 

Report Metric Details
 Market Size Value in 2020  US$1,733.074 million
 Market Size Value in 2027  US$2,320.075 million
 Growth Rate  CAGR of 4.26% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Million
 Segments Covered  Type, Age Group, Application, End-User, And Geography
 Regions Covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies Covered Boston Scientific Corporation, GBUK Enteral Ltd., Nestle SA, B.Braun Melsungen AG, Cardinal Health, Inc., Vygon (UK) Ltd, Avanos Medical, Inc., Rockfield Medical Devices, Applied Medical Technology, Inc., Fresenius SE & Co. KGaA, Conmed Corporation, Moog Inc.
 Customization Scope  Free report customization with purchase

 

Market Segments

  • By Type
    • Enteral Feeding Pumps
    • Enteral Feeding Tubes
    • Enteral Syringes
    • Others
  • By Age Group
    • Adult
    • Pediatric
  • By Application
    • Gastroenterology
    • Oncology
    • Neurology
    • Hypermetabolism
    • Diabetes
    • Others
  • By End-User
    • Hospitals
    • Home Care
    • Ambulatory Care Settings
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • U.K.
      • Others
    • The Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      •  China
      • Japan
      • India
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

The enteral feeding devices market is projected to reach a total market size of US$2,320.075 million by 2027.
Enteral Feeding Devices Market was valued at US$1,733.074 million in 2020.
The global enteral feeding devices market is projected to grow at a CAGR of 4.26% during the forecast period.
North America is anticipated to dominate the enteral feeding devices market due to the rising adoption of this device followed by advanced treatment approaches in healthcare.
A rising geriatric population that gets bedridden due to various neurological and musculoskeletal disorders is further expected to boost the enteral feeding devices market growth.

1. INTRODUCTION

1.1. Market Overview

1.2. COVID-19 Scenario

1.3. Market Definition

1.4. Market Segmentation

 

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

 

3. EXECUTIVE SUMMARY

3.1. Research Highlights

 

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

 

5. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY TYPE

5.1. Introduction

5.2. Enteral Feeding Pumps

5.3. Enteral Feeding Tubes

5.4. Enteral Syringes

5.5. Others

 

6. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP

6.1. Introduction

6.2. Adult

6.3. Paediatric

 

7. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY APPLICATION

7.1. Introduction

7.2. Gastroenterology

7.3. Oncology

7.4. Neurology

7.5. Hypermetabolism

7.6. Diabetes

7.7. Others

 

8. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY END-USER

8.1. Introduction

8.2. Hospitals

8.3. Home Care

8.4. Ambulatory Care Settings

 

9. GLOBAL ENTERAL FEEDING DEVICES MARKET,, BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. U.K

9.4.4. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. Japan

9.6.3. India

9.6.4. South Korea

9.6.5. Taiwan

9.6.6. Thailand

9.6.7. Indonesia

9.6.8. Others

 

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Emerging Players and Market Lucrativeness

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Vendor Competitiveness Matrix

 

11. COMPANY PROFILES

11.1. Boston Scientific Corporation

11.2. GBUK Enteral Ltd.

11.3. Nestle SA

11.4. B.Braun Melsungen AG

11.5. Cardinal Health, Inc.

11.6. Vygon (UK) Ltd

11.7. Avanos Medical, Inc.

11.8. Rockfield Medical Devices

11.9. Applied Medical Technology, Inc.

11.10. Fresenius SE & Co. KGaA

11.11. Conmed Corporation

11.12. Moog Inc.


Boston Scientific Corporation

GBUK Enteral Ltd.

Nestle SA

B.Braun Melsungen AG

Cardinal Health, Inc.

Vygon (UK) Ltd

Avanos Medical, Inc.

Rockfield Medical Devices

Applied Medical Technology, Inc.

Fresenius SE & Co. KGaA

Conmed Corporation

Moog Inc.


Related Reports

Report Name Published Month Get Sample PDF
Mechanical Ventilator Market Size: Industry Report 2022 - 2027
Pain Management Devices Market Size: Industry Report 2022 - 2027
Fetal & Neonatal Care Equipment Market Size: Report 2022-2027
Carbon Dioxide Incubators Market Size: Report 2022 - 2027
Insulin Delivery Devices Market Size & Share: Report 2022 - 2027